Pakistan’s pharmaceutical sector recorded its highest-ever annual profit of Rs. 42.2 billion in fiscal year 2026, supported by record profit margins and a sharp decline in financing costs.
According to data compiled by Topline Securities, the sector’s profit increased by 28 percent year-on-year in FY26, while annual profit margins reached a record 42.8 percent. Finance costs also fell by 42 percent compared with the previous fiscal year, helping boost earnings.
The sector recorded a compound annual growth rate of around 14 percent in profits between FY17 and FY26, reflecting sustained earnings growth over the nine-year period.
Despite the strong financial performance, the sector’s combined market capitalization increased by only 2 percent year-on-year as of June 30, 2026.
The limited increase in market value stands in contrast to the 28 percent growth in annual earnings. This means that stronger profitability did not translate into a similar rise in the sector’s overall market capitalization.
The post Pharma Sector Records Highest-Ever Annual Profit appeared first on ProPakistani.
